NOCIL Past Earnings Performance
Past criteria checks 2/6
NOCIL has been growing earnings at an average annual rate of 0.2%, while the Chemicals industry saw earnings growing at 16.6% annually. Revenues have been growing at an average rate of 15.9% per year. NOCIL's return on equity is 7.3%, and it has net margins of 8.1%.
Key information
0.2%
Earnings growth rate
-0.06%
EPS growth rate
Chemicals Industry Growth | 17.7% |
Revenue growth rate | 15.9% |
Return on equity | 7.3% |
Net Margin | 8.1% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How NOCIL makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 14,809 | 1,198 | 932 | 0 |
30 Sep 23 | 14,660 | 1,084 | 907 | 0 |
30 Jun 23 | 15,043 | 1,170 | 880 | 0 |
31 Mar 23 | 16,166 | 1,492 | 876 | 0 |
31 Dec 22 | 16,866 | 1,898 | 869 | 0 |
30 Sep 22 | 17,498 | 2,009 | 849 | 0 |
30 Jun 22 | 17,357 | 1,952 | 832 | 0 |
31 Mar 22 | 15,713 | 1,761 | 809 | 0 |
31 Dec 21 | 14,306 | 1,445 | 825 | 0 |
30 Sep 21 | 13,162 | 1,370 | 813 | 0 |
30 Jun 21 | 11,627 | 1,239 | 800 | 0 |
31 Mar 21 | 9,247 | 884 | 702 | 0 |
31 Dec 20 | 8,153 | 730 | 752 | 0 |
30 Sep 20 | 7,351 | 716 | 763 | 0 |
30 Jun 20 | 7,232 | 1,097 | 775 | 0 |
31 Mar 20 | 8,463 | 1,307 | 815 | 0 |
31 Dec 19 | 8,752 | 1,450 | 853 | 0 |
30 Sep 19 | 9,421 | 1,689 | 813 | 0 |
30 Jun 19 | 10,044 | 1,668 | 791 | 0 |
31 Mar 19 | 10,429 | 1,849 | 780 | 0 |
31 Mar 18 | 9,676 | 1,699 | 786 | 0 |
31 Mar 17 | 7,422 | 971 | 716 | 0 |
31 Mar 16 | 7,152 | 783 | 638 | 0 |
31 Mar 15 | 7,190 | 571 | 534 | 0 |
31 Mar 14 | 5,961 | 239 | 662 | 0 |
Quality Earnings: 500730 has high quality earnings.
Growing Profit Margin: 500730's current net profit margins (8.1%) are lower than last year (11.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 500730's earnings have grown by 0.2% per year over the past 5 years.
Accelerating Growth: 500730's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 500730 had negative earnings growth (-36.9%) over the past year, making it difficult to compare to the Chemicals industry average (-6.1%).
Return on Equity
High ROE: 500730's Return on Equity (7.3%) is considered low.